Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Zile, Michael
One or more keywords matched the following items that are connected to Zile, Michael
Item TypeName
Academic Article Irbesartan in patients with heart failure and preserved ejection fraction.
Academic Article Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
Academic Article The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
Academic Article Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Academic Article Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
Academic Article Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
Academic Article Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure.
Academic Article Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Concept Hospitalization
Academic Article Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
Academic Article Angiotensin-neprilysin inhibition versus enalapril in heart failure.
Academic Article History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
Academic Article International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Academic Article A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.
Academic Article Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
Academic Article Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
Academic Article Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
Academic Article The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Academic Article Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Academic Article Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Academic Article Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
Academic Article Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Academic Article Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial.
Academic Article Influence of Sacubitril/Valsartan (LCZ696)?on?30-Day Readmission After Heart Failure Hospitalization.
Academic Article Efficacy of Sacubitril/Valsartan Relative to?a Prior Decompensation: The PARADIGM-HF Trial.
Academic Article Geographic variations in the PARADIGM-HF heart failure trial.
Academic Article Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction.
Academic Article Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
Academic Article Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Academic Article Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
Academic Article The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
Academic Article Heart Rate and Outcomes in Hospitalized?Patients With Heart Failure With Preserved Ejection?Fraction.
Academic Article Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Academic Article Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
Academic Article Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of?Heart Failure.
Academic Article Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
Academic Article Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
Academic Article Heart Failure With Preserved Ejection Fraction in the Young.
Academic Article Differential Impact of Heart Failure With?Reduced Ejection Fraction on?Men?and?Women.
Academic Article Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients?With HFrEF.
Academic Article Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
Academic Article Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Academic Article Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Academic Article Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Academic Article Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
Academic Article Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
Academic Article Prediction of heart failure hospitalizations based on the direct measurement of intrathoracic impedance.
Academic Article Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Academic Article Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Academic Article Covariate adjusted reanalysis of the I-Preserve trial.
Academic Article The prevalence and importance of frailty in heart failure with reduced ejection fraction?-?an analysis of PARADIGM-HF and ATMOSPHERE.
Academic Article Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
Academic Article Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population.
Academic Article Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
Academic Article Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
Academic Article Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Academic Article Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Academic Article Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization.
Academic Article Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Academic Article Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.
Search Criteria
  • Hospitalization